🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Chimeric antigen receptor (CAR)-modified T cells can mediate long-term dura...
Status
Unknown
Location
Sanbo Brain Hospital Capital Medical University
Start Date
2016-07
Trial ID
NCT02844062
Treatments Being Tested
This is a multicenter, open-label, Phase 1/2 master protocol evaluating aut...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07523529
Immunotherapy has become the major breakthrough and the most promising trea...
Status
Unknown
Location
Harbin Medical University
Start Date
2017-06-15
Trial ID
NCT03267173
Treatments Being Tested
This is a single-center, open, dose-increasing study. For subjects with rec...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-15
Trial ID
NCT05802693
This phase I trial investigates the efficacy and safety of brain-targeting ...
Status
Unknown
Location
Jyväskylä Central Hospital
Start Date
2020-05-15
Trial ID
NCT05063682
An Open-Label Phase 1 Pilot Study to determine the safety and feasibility o...
Status
Terminated
Location
UCSF
Start Date
2014-11-18
Trial ID
NCT02209376
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of E-SYNC ...
Status
Recruiting
Location
University of California, San Francisco
Start Date
2024-04-30
Trial ID
NCT06186401
This is a single arm, open-label, uni-center, phase I-II study to evaluate ...
Status
Unknown
Location
Henan Provincial People's Hospital
Start Date
2019-09-01
Trial ID
NCT03941626
Treatments Being Tested
The goal of this protocol is to transfer autologous peripheral blood mononu...
Status
Terminated
Location
Duke University Medical Center
Start Date
2018-05-30
Trial ID
NCT03283631
Treatments Being Tested
The goal of this research study is to determine the best dose of CARv3-TEAM...
Status
Recruiting
Location
Massachusetts General Hospital Cancer Center
Start Date
2023-03-22
Trial ID
NCT05660369
Treatments Being Tested